Document Detail


An update on electrical cardioversion of atrial fibrillation.
MedLine Citation:
PMID:  14739729     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atrial fibrillation is the most frequently encountered sustained arrhythmia in clinical practice. Electrical cardioversion of atrial fibrillation using damped sine wave shocks has been a mainstay of therapy for nearly 4 decades; its limitation remains a failure rate that approaches 20%. Although several alternatives have been proposed, including delivering 720 J shocks using dual monophasic defibrillators, ibutilide pretreatment and internal cardioversion, each of these approaches has significant limitations, which preclude its routine use. Recent data demonstrate that routine use of biphasic shocks for cardioversion of atrial fibrillation is associated with a marked improvement in cardioversion efficacy and suggest that biphasic shocks may be the preferred method for the transthoracic electrical cardioversion of atrial fibrillation.
Authors:
Suneet Mittal; Kenneth M Stein; Steven M Markowitz; Sei Iwai; Amit Guttigoli; Bruce B Lerman
Related Documents :
9230619 - Long-term prevention of atrial fibrillation after coronary artery surgery.
9692479 - Left atrial reduction for chronic atrial fibrillation associated with mitral valve dise...
9683909 - Evidence for an influence of mechanical restitution on beat-to-beat variations in haemo...
22126629 - Quad-site pacing using a quadripolar left ventricular pacing lead.
6839569 - Prediction of in-hospital ventricular fibrillation from admission data in acute myocard...
22561299 - Left ventricular endocardial or triventricular pacing to optimize cardiac resynchroniza...
3668249 - Low mortality from all causes, including myocardial infarction, in well-controlled hype...
18195669 - Antiplatelet agents and randomized trials.
9527149 - Respiratory insufficiency due to high anterior cervical cord infarction.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiac electrophysiology review     Volume:  7     ISSN:  1385-2264     ISO Abbreviation:  Card Electrophysiol Rev     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2004-01-23     Completed Date:  2004-06-17     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9708907     Medline TA:  Card Electrophysiol Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  285-9     Citation Subset:  IM    
Affiliation:
Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York, NY 10021, USA. sum2010@med.cornell.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation / therapy*
Electric Countershock* / methods
Humans
Sulfonamides / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Sulfonamides; 130350-52-6/ibutilide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Time to first recurrence as a trial endpoint: time to change?
Next Document:  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation.